Skip to main content

Publication, Part of

Cancer Registration Statistics, England, 2022

National statistics, Accredited official statistics

Accredited official statistics logo.

New data added:

  • Incidence counts and rates have been re-stated for cancers diagnosed between 2012 to 2022, reflecting the updated populations available using the 2021 census
  • Counts and rates have been provided for Persons in addition to Males and Females
  • We now use https://fingertips.phe.org.uk/documents/2021-lsoa-imd-lookup.xlsx to align deprivation scores with 2021 LSOAs
  • The data downloads for Cancer Registrations (Incidence)  now contain counts and age-standardised rates for England only. The interactive dashboard contains counts, age-specific, non-standardised and age-standardised rates for England and sub-national geographies

Coming Summer 2025:

  • Incidence counts and rates for small geographic areas including, Upper Tier Local Authority (UTLA) 2024 boundaries, Local authority district / unitary authority (LAUA) 2024 boundaries and Middle layer super output area (MSOA) using census 2021

5 June 2025 11:00 AM

Correction notice:

A coding error has resulted in incorrect populations being used as a denominator for age-specific rates for sub-national estimates. This has affected Tables 1 to 4.  The coding error has been fixed and the age-specific rates  for Government office regions, Cancer alliances,  and Integrated care boards have been updated to the correct values.

12 November 2024 12:25 PM

Page contents

Cancer incidence by deprivation quintile

The Index of Multiple Deprivation (IMD) is the official measure of relative deprivation for small areas in England and is based on the postcode of residence at diagnosis. The 2019 IMD was grouped into quintiles, which were weighted so that the quintiles were equal in terms of the number of Lower-layer Super Output Areas (LSOAs). 

Estimates for most main and detailed cancer groups suggest that incidence is higher in the most deprived quintiles for both males and females. Small cell lung cancer has some of the biggest proportionate changes between quintiles for both males and females.

Figure 4 shows the age-standardised cancer incidence rate for small cell lung cancer for males and females. The rates are nearly 4 times higher for females living in the most deprived areas (11 per 100,000) when compared with the least deprived areas (3 per 100,000). The rates were 3 time higher for males living in the most deprived areas (12 per 100,000) when compared with the least deprived areas (4 per 100,000). 

 

Figure 4: Age-standardised cancer incidence rates per 100,000 people (small cell lung cancer) by IMD quintile for males and females, England, 2022

Although for most cancers the age-standardised cancer incidence rate is highest for people living in the most deprived areas, there are some cancers where the rate is highest for people living in the least deprived areas. For example, prostate cancer, breast cancer, and melanoma of skin.

Figure 5 shows that for both males and females, the age-standardised cancer incidence rate for people with melanoma living in the least deprived areas was twice as high as the rate for people living in the most deprived areas. For males, the rate was 22 per 100,000 people living in the most deprived areas and 46 per 100,000 people living in the least deprived areas. For females, the rate was 19 per 100,000 people living in the most deprived areas and 37 per 100,000 people living in the least deprived areas. 

 

Figure 5: Age-standardised cancer incidence rates per 100,000 people (melanoma) by IMD quintile for males and females, England, 2022

In certain cancer groupings there is no discernible relationship with IMD. Although the rates of diagnosis differ between males and females, the estimates of diffuse large B-cell lymphoma (DLBCL) and other high grade mature B-cell neoplasms by quintile for each gender are similar.  Figure 6 presents the age-standardised cancer incidence rates in 2021 for both males and females diagnosed with DLBCL and other high grade mature B-cell neoplasms, one of the most common forms of blood cancer.

 

Figure 6: Age-standardised cancer incidence rates per 100,000 people (diffuse large B-cell lymphoma and other high grade mature B-cell neoplasms) by IMD quintile for males and females, England, 2022

Other detailed groups showing similar patterns to DLCBL include acute lymphoblastic leukaemia, essential thrombocythaemia and non-benign endocrine cancers of the brain and central nervous system. 



Last edited: 10 June 2025 11:46 am